Alignment Healthcare, Inc.
ALHC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $2 | $1 | $1 |
| % Growth | 48.3% | 27.2% | 22.8% | – |
| Cost of Goods Sold | $2 | $2 | $1 | $1 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 11% | 11% | 12.8% | 11% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3.8% | -7% | -9% | -15.2% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4.7% | -8.1% | -10.4% | -16.7% |
| EPS | -0.67 | -0.79 | -0.83 | -1.14 |
| % Growth | 15.2% | 4.8% | 27.2% | – |
| EPS Diluted | -0.67 | -0.79 | -0.83 | -1.14 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2.9% | -5.8% | -7.9% | -13.9% |